Stocks
Health Care
bmrn
Biomarin Pharmaceutical
BMRN
-0.48 (-0.89%)
54.205
USD
At close at Jun 25, 18:36 UTC
Income Statement
Revenue
2.85B
Gross Profit
2.27B
Operating Income
484.21M
Pretax Income
674.30M
Net Income
426.86M
EBITDA
650.86M
EBIT
554.43M
Earnings Per Share
2.25
Balance Sheet
Cash & Cash Equivalents
834.36M
Total Debt
841.67M
Net Cash
4.37B
Net Cash Per Share
22.78
Equity (Book Value)
5.36B
Book Value Per Share
28.22
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.